
Kies je etiket
direct zichtbaar op de vialRAD-140 (Testolone)
SARMs
- Verzonden vanuit Duitsland
Bestelling
- DHL met tracking
- Discrete verpakking
4.6 van 5 op Trustpilot73 reviews
Ook gezocht als: Testolon
In één oogopslag
RAD-140 (Testolone) in cijfers
De kerncijfers uit ons lexicon. Sleep het punt langs de curve om te zien hoeveel er na één dosis rekenkundig nog over is.
Volledig lexiconartikelHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~1.9 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
44.7hours
measured in humans
- Class
- SARMnon-steroidal
- Use
- Oraldaily
- Sizes
- 10 mg1 size in the shop
What studies show
All 4 sources in the lexicon- Miller et al., ACS Medicinal Chemistry Letters, 2011
RAD140 inhibits the growth of AR-positive breast cancer models (preclinical) (opens in a new tab)
Yu et al., Clinical Cancer Research, 2017Documented case of liver injury under RAD-140 outside clinical trials (opens in a new tab)
Ladna et al., Journal of Medical Case Reports, 2023
Er is nog geen labanalyse voor RAD-140 (Testolone). Stem eropLaat het zelf testen, wij betalen de helftAlle labanalyses
Kennis
Alles over RAD-140 (Testolone)
Uitgebreide informatie volgt binnenkort.
How does RAD-140 work?
According to ChEMBL RAD-140 binds to the androgen receptor with a Ki of 7 nM and activated it in muscle cells in the lab. Yu and colleagues found that it activates the receptor in breast cancer cells but not in prostate cancer cells. That is the tissue preference SARMs aim for.
Is RAD-140 approved?
No. On ClinicalTrials.gov there is a single study for RAD140, the completed phase 1 study in breast cancer (as of 26 October 2026). There are no studies in healthy people. Everything here is the state of research, not a recommendation.
What did the phase 1 study show?
22 heavily pretreated women with breast cancer took RAD-140 daily. SHBG fell in all 18 women measured, PSA rose in 16 of 20, a sign of action at the receptor. After 24 weeks 18.2 percent had a benefit, one woman a partial response. Liver values rose often.
What about the liver?
In the phase 1 study AST rose in 59.1 percent, ALT in 45.5 percent. In addition there are case reports. A 26-year-old had acute liver injury, his values normalised two months after stopping. A 24-year-old developed cholestatic liver injury after five weeks of use.
Are there reports on the heart?
Yes, as a case report: Padappayil and colleagues describe a young man with possible acute myocarditis after self-use of RAD-140 for bodybuilding. A case report does not prove a link, but it shows what to watch for.
Is muscle gain proven in humans?
No. The first description by Miller and colleagues shows anabolic effects in animal models. In humans there is only the phase 1 study in women with breast cancer, which did not measure muscle mass.
Vergelijkingen
Hoe het zich verhoudt
Gerelateerd
Gerelateerde producten
RAD-140 (Testolone)

